Transcranial Magnetic Stimulation (TMS) ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 13 | 多発性硬化症／視神経脊髄炎 | 1 |
13. 多発性硬化症／視神経脊髄炎
臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04062331 (ClinicalTrials.gov) | October 1, 2019 | 1/8/2019 | Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis | Clinical and Neurochemical Effects of Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis | Multiple Sclerosis | Device: Transcranial Magnetic Stimulation (TMS);Drug: Placebos | Maimónides Biomedical Research Institute of Córdoba | Isaac Tunez-Fiñana;Eduardo Agüera-Morales | Not yet recruiting | 14 Years | N/A | All | 90 | Phase 1/Phase 2 | NULL |